{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:33:51Z","timestamp":1777901631265,"version":"3.51.4"},"reference-count":131,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.rdc.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T23:11:37Z","timestamp":1385075497000},"page":"103-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Pulmonary Arterial Hypertension Related to Connective Tissue Disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Saman","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harold I.","family":"Palevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rdc.2013.10.001_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.10100725","article-title":"Right and left ventricular myocardial perfusion reserves correlate with right ventricular function and pulmonary hemodynamics in patients with pulmonary arterial hypertension","volume":"258","author":"Vogel-Claussen","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0029-1233312","article-title":"Pulmonary arterial hypertension complicating connective tissue diseases","volume":"30","author":"Hassoun","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2013.10.001_bib3","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1055\/s-0030-1263315","article-title":"Pulmonary hypertension: hemodynamic evaluation: hemodynamic evaluation\u2014recommendations of the Cologne Consensus Conference 2010","volume":"135","author":"Opitz","year":"2010","journal-title":"Dtsch Med Wochenschr"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.001_bib4","article-title":"Diagnosis and classification of pulmonary hypertension","volume":"39","author":"Montani","year":"2010","journal-title":"Presse Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1055\/s-0029-1233306","article-title":"Definition, classification, and epidemiology of pulmonary arterial hypertension","volume":"30","author":"Hoeper","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib7","article-title":"Pulmonary arterial pressure during rest and exercise (from Geneva, 1961 to Dana Point, 2008)","volume":"1","author":"Kovacs","year":"2010","journal-title":"Annals of Respiratory Medicine"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib8","first-page":"1897","article-title":"A\u00a0new clinical classification of pulmonary hypertension","volume":"193","author":"Simonneau","year":"2009","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.rdc.2013.10.001_bib9","unstructured":"Rich S. Primary pulmonary hypertension: executive summary from the World Symposium (Evian, France - 1998). 1998. Available at: http:\/\/www.who.int\/ncd\/cvd\/pph.htm. Accessed August 1, 2013."},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0272-5231(05)70278-1","article-title":"Clinical classification of pulmonary hypertension","volume":"22","author":"Fishman","year":"2001","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-5231(05)70284-7","article-title":"Risk factors for pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2001","journal-title":"Clin Chest Med"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1751-7133.2010.00192.x","article-title":"Differentiating pulmonary arterial and pulmonary venous hypertension and the implications for therapy","volume":"16","author":"Dadfarmay","year":"2010","journal-title":"Congest Heart Fail"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib13","first-page":"529","article-title":"Primary pulmonary hypertension","volume":"55","author":"Fauzi","year":"2000","journal-title":"Med J Malaysia"},{"key":"10.1016\/j.rdc.2013.10.001_bib14","first-page":"S1","article-title":"Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension (Venice, Italy) June 23-25, 2003","volume":"43","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib15","first-page":"458","article-title":"Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization","volume":"35","author":"Hsu","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.001_bib16","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0889-857X(05)70335-5","article-title":"Pulmonary hypertension in systemic autoimmune disease","volume":"23","author":"Gurubhagavatula","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1183\/09031936.02.00068002","article-title":"Haemodynamic evaluation of pulmonary hypertension","volume":"20","author":"Chemla","year":"2002","journal-title":"Eur Respir J"},{"issue":"12 Suppl S","key":"10.1016\/j.rdc.2013.10.001_bib19","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.001_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4070\/kcj.2010.40.9.459","article-title":"Gene expression of endothelin-1 and endothelin receptor a on monocrotaline-induced pulmonary hypertension in rats after bosentan treatment","volume":"40","author":"Lim","year":"2010","journal-title":"Korean Circ J"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.vph.2012.09.001","article-title":"Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension","volume":"58","author":"Chen","year":"2012","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib22","first-page":"773","article-title":"Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics","volume":"12","author":"Mahowald","year":"1985","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.001_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajpath.2011.03.040","article-title":"Plexiform lesions in pulmonary arterial hypertension composition, architecture, and microenvironment","volume":"179","author":"Jonigk","year":"2011","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/2045-8932.114756","article-title":"Gender, sex hormones and pulmonary hypertension","volume":"3","author":"Austin","year":"2013","journal-title":"Pulm Circ"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2013.10.001_bib26","series-title":"Current diagnosis and treatment in pulmonary medicine","article-title":"Pulmonary arterial hypertension","author":"Fagan","year":"2003"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.001_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1378\/chest.11-1149","article-title":"The early diagnosis of pulmonary arterial hypertension: can we do better?","volume":"140","author":"Palevsky","year":"2011","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib28","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ajh.2010.188","article-title":"Diagnostic value of transthoracic Doppler echocardiography in pulmonary hypertension: a meta-analysis","volume":"23","author":"Zhang","year":"2010","journal-title":"Am J Hypertens"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1536\/ihj.51.343","article-title":"Utility of echocardiography versus BNP level for the prediction of pulmonary arterial pressure in patients with pulmonary arterial hypertension","volume":"51","author":"Goto","year":"2010","journal-title":"Int Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.001_bib30","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib31","first-page":"235","article-title":"Evaluation of the functional parameters in scleroderma cases with pulmonary involvement","volume":"58","author":"Celebi Sozener","year":"2010","journal-title":"Tuberk Toraks"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0761-8425(08)71585-7","article-title":"Pulmonary arterial hypertension in women","volume":"25","author":"Sanchez","year":"2008","journal-title":"Rev Mal Respir"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.001_bib33","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.3899\/jrheum.110512","article-title":"Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension","volume":"38","author":"Mathai","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1254\/jphs.12114FP","article-title":"Acute vasoreactivity testing with nicardipine in patients with pulmonary arterial hypertension","volume":"120","author":"Saito","year":"2012","journal-title":"J\u00a0Pharmacol Sci"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib35","first-page":"678","article-title":"Incidence and significance of pericardial effusion in patients with pulmonary arterial hypertension","volume":"29","author":"Shimony","year":"2013","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.80.2.353","article-title":"Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension","volume":"80","author":"Eysmann","year":"1989","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.21693\/1933-088X-9.2.107","article-title":"What can be learned in 6 minutes? 6-minute walk test: primer and role in pulmonary arterial hypertension","volume":"9","author":"Burger","year":"2010","journal-title":"Adv Pulm Hypertens"},{"issue":"Suppl 5","key":"10.1016\/j.rdc.2013.10.001_bib38","doi-asserted-by":"crossref","first-page":"v68","DOI":"10.1093\/rheumatology\/ken273","article-title":"The 6-minute walk test in scleroderma\u2014how measuring everything measures nothing","volume":"47","author":"Impens","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2013.10.001_bib39","series-title":"Principles of exercise testing and interpretation","author":"Wasserman","year":"2005"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1183\/09031936.00067011","article-title":"Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension","volume":"39","author":"Heresi","year":"2012","journal-title":"Eur Respir J"},{"issue":"13","key":"10.1016\/j.rdc.2013.10.001_bib41","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/hrt.2011.224857","article-title":"Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension","volume":"97","author":"Rhodes","year":"2011","journal-title":"Heart"},{"issue":"Suppl 6","key":"10.1016\/j.rdc.2013.10.001_bib42","doi-asserted-by":"crossref","first-page":"32S","DOI":"10.1016\/j.amjcard.2012.06.014","article-title":"The potential of biomarkers in pulmonary arterial hypertension","volume":"110","author":"Cracowski","year":"2012","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/03009742.2010.507217","article-title":"Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease","volume":"40","author":"Hesselstrand","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1164\/rccm.200208-899OC","article-title":"Pulmonary embolism: comparison of angiography with spiral computed tomography, magnetic resonance angiography, and real-time magnetic resonance imaging","volume":"167","author":"Haage","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib45","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1161\/01.CIR.80.5.1486","article-title":"Primary pulmonary hypertension. The risk and benefit of lung biopsy","volume":"80","author":"Nicod","year":"1989","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib46","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/rheumatology\/kep203","article-title":"Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus","volume":"48","author":"Prabu","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"113","key":"10.1016\/j.rdc.2013.10.001_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1183\/09059180.00003209","article-title":"Screening for pulmonary arterial hypertension in systemic sclerosis","volume":"18","author":"Vachiery","year":"2009","journal-title":"Eur Respir Rev"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib48","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.110987","article-title":"Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease","volume":"39","author":"Rajaram","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.001_bib49","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jacc.2009.04.018","article-title":"Cellular and molecular basis of pulmonary arterial hypertension","volume":"54","author":"Morrell","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.001_bib50","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1445-5994.2007.01370.x","article-title":"Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment","volume":"37","author":"Proudman","year":"2007","journal-title":"Intern Med J"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib51","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1378\/chest.10-0260","article-title":"Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype","volume":"138","author":"Chung","year":"2010","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.001_bib52","first-page":"1812","article-title":"Prevalence of exercise pulmonary arterial hypertension in scleroderma","volume":"35","author":"Callejas-Rubio","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib53","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/rheumatology\/kep258","article-title":"Pulmonary arterial hypertension in systemic lupus erythematosus: should we bother?","volume":"48","author":"Bijl","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.001_bib54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/35.10.989","article-title":"Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients","volume":"35","author":"Koh","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib55","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib56","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1586\/ers.09.5","article-title":"Therapies for scleroderma-related pulmonary arterial hypertension","volume":"3","author":"Hassoun","year":"2009","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.001_bib57","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00003495-200767070-00004","article-title":"Scleroderma lung: pathogenesis, evaluation and current therapy","volume":"67","author":"van Laar","year":"2007","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.001_bib58","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0761-8425(08)75093-9","article-title":"Respiratory involvement in systemic lupus erythematosus","volume":"25","author":"Carmier","year":"2008","journal-title":"Rev Mal Respir"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2013.10.001_bib59","first-page":"iii54","article-title":"Vasculopathy and pulmonary arterial hypertension","volume":"48","author":"Guillevin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MD.0b013e3181579781","article-title":"Pulmonary arterial hypertension: a rare complication of primary Sjogren syndrome: report of 9 new cases and review of the literature","volume":"86","author":"Launay","year":"2007","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib61","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0761-8425(06)72081-2","article-title":"Pulmonary involvement in polymyositis and dermatomyositis","volume":"23","author":"Tillie-Leblond","year":"2006","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rdc.2013.10.001_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/s10165-003-0205-1","article-title":"Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis","volume":"13","author":"Nagasaka","year":"2003","journal-title":"Mod Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.001_bib63","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.clinthera.2007.10.009","article-title":"Evidence-based pharmacologic management of pulmonary arterial hypertension","volume":"29","author":"Benedict","year":"2007","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib64","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","article-title":"Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease","volume":"126","author":"Oudiz","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/pr.111.005587","article-title":"The pharmacological treatment of pulmonary arterial hypertension","volume":"64","author":"Frumkin","year":"2012","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib66","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/BOR.0b013e3283307dc8","article-title":"Therapy for pulmonary arterial hypertension associated with systemic sclerosis","volume":"21","author":"Mathai","year":"2009","journal-title":"Curr Opin Rheumatol"},{"issue":"12 Suppl S","key":"10.1016\/j.rdc.2013.10.001_bib67","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1016\/j.jacc.2004.02.038","article-title":"Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"43","author":"Galie","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.rdc.2013.10.001_bib68","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMra040291","article-title":"Treatment of pulmonary arterial hypertension","volume":"351","author":"Humbert","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib69","first-page":"427","article-title":"Addition of sildenafil in patients with pulmonary arterial hypertension and inadequate response to bosentan monotherapy","volume":"15","author":"Porhownik","year":"2008","journal-title":"Can Respir J"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2013.10.001_bib70","first-page":"iii25","article-title":"Pulmonary arterial hypertension: the most devastating vascular complication of systemic sclerosis","volume":"48","author":"McLaughlin","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib71","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12325-011-0005-5","article-title":"Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy","volume":"28","author":"Vachiery","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.rdc.2013.10.001_bib72","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2147\/VHRM.S14777","article-title":"Inhaled treprostinil and pulmonary arterial hypertension","volume":"6","author":"Nadler","year":"2010","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib73","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00002281-200211000-00010","article-title":"Targeting mediators of vascular injury in scleroderma","volume":"14","author":"Schachna","year":"2002","journal-title":"Curr Opin Rheumatol"},{"issue":"12 Suppl S","key":"10.1016\/j.rdc.2013.10.001_bib74","doi-asserted-by":"crossref","first-page":"56S","DOI":"10.1016\/j.jacc.2004.02.036","article-title":"Prostanoid therapy for pulmonary arterial hypertension","volume":"43","author":"Badesch","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib75","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1183\/09031936.00137511","article-title":"Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension","volume":"40","author":"Simonneau","year":"2012","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2013.10.001_bib76","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.126.1_suppl.35S","article-title":"Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Badesch","year":"2004","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib77","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A\u00a0comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","volume":"334","author":"Barst","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-121-6-199409150-00003","article-title":"Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin","volume":"121","author":"Barst","year":"1994","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib79","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","article-title":"Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion","volume":"30","author":"Shapiro","year":"1997","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib80","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib81","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib82","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib83","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1183\/09031936.99.13613579","article-title":"Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study","volume":"13","author":"Humbert","year":"1999","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.rdc.2013.10.001_bib84","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3899\/jrheum.081277","article-title":"Long-term survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol","volume":"36","author":"Badesch","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib85","first-page":"179","article-title":"Medical and surgical treatment options for pulmonary hypertension","volume":"315","author":"Gaine","year":"1998","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension","volume":"336","author":"Rubin","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"6163","key":"10.1016\/j.rdc.2013.10.001_bib87","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A\u00a0novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.001_bib88","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.CIR.94.7.1578","article-title":"Human pulmonary circulation is an important site for both clearance and production of endothelin-1","volume":"94","author":"Dupuis","year":"1996","journal-title":"Circulation"},{"issue":"9288","key":"10.1016\/j.rdc.2013.10.001_bib89","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib90","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"9630","key":"10.1016\/j.rdc.2013.10.001_bib91","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Galie","year":"2008","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.rdc.2013.10.001_bib92","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.rdc.2013.10.001_bib93","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/jm3009103","article-title":"The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist","volume":"55","author":"Bolli","year":"2012","journal-title":"J\u00a0Med Chem"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib94","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ehj.2004.01.013","article-title":"Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects","volume":"25","author":"Mikhail","year":"2004","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.rdc.2013.10.001_bib95","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.0000016641.12984.DC","article-title":"Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.rdc.2013.10.001_bib96","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib97","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia-induced pulmonary hypertension","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.001_bib98","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.rdc.2013.10.001_bib99","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/rccm.200410-1411OC","article-title":"Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study","volume":"171","author":"Wilkins","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib100","first-page":"2417","article-title":"Sildenafil for pulmonary arterial hypertension associated with connective tissue disease","volume":"34","author":"Badesch","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib101","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1358\/dot.2011.47.2.1544337","article-title":"Novel therapeutic approaches in pulmonary arterial hypertension: focus on tadalafil","volume":"47","author":"Levin","year":"2011","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.rdc.2013.10.001_bib102","first-page":"273","article-title":"The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension","volume":"6","author":"Falk","year":"2010","journal-title":"Vasc Health Risk Manag"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib103","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2012.05.004","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study","volume":"60","author":"Oudiz","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.rdc.2013.10.001_bib104","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nrd3297","article-title":"Targeting non-malignant disorders with tyrosine kinase inhibitors","volume":"9","author":"Grimminger","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.rdc.2013.10.001_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2010.07.003","article-title":"Vascular remodeling in pulmonary arterial hypertension: multiple cancer-like pathways and possible treatment modalities","volume":"147","author":"Sakao","year":"2011","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.001_bib106","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1164\/rccm.201001-0123OC","article-title":"Imatinib in pulmonary arterial hypertension patients with inadequate response to established therapy","volume":"182","author":"Ghofrani","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib107","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1080\/10428190310001615666","article-title":"Subdural hematomas during CML therapy with imatinib mesylate","volume":"45","author":"Song","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"10.1016\/j.rdc.2013.10.001_bib108","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3109\/10428194.2011.566950","article-title":"Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy","volume":"52","author":"Patel","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib109","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1183\/09031936.00010609","article-title":"Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern","volume":"33","author":"Michelakis","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib110","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/13543784.2011.565048","article-title":"Riociguat for the treatment of pulmonary hypertension","volume":"20","author":"Schermuly","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.rdc.2013.10.001_bib111","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib112","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/cmdc.200900014","article-title":"Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension","volume":"4","author":"Mittendorf","year":"2009","journal-title":"ChemMedChem"},{"issue":"9","key":"10.1016\/j.rdc.2013.10.001_bib113","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4187\/respcare.01442","article-title":"Inhaled medical gases: more to breathe than oxygen","volume":"56","author":"Gentile","year":"2011","journal-title":"Respir Care"},{"issue":"5","key":"10.1016\/j.rdc.2013.10.001_bib114","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.05.00075305","article-title":"Goal-oriented treatment and combination therapy for pulmonary arterial hypertension","volume":"26","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.healun.2011.11.002","article-title":"Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study","volume":"31","author":"Kemp","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib116","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.rdc.2013.10.001_bib117","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2011.06.021","article-title":"Meta-analysis of monotherapy versus combination therapy for pulmonary arterial hypertension","volume":"108","author":"Fox","year":"2011","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib118","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","article-title":"Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2","volume":"24","author":"Humbert","year":"2004","journal-title":"Eur Respir J"},{"issue":"18","key":"10.1016\/j.rdc.2013.10.001_bib119","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2010.01.027","article-title":"Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial","volume":"55","author":"McLaughlin","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/ers.11.21","article-title":"Pulmonary arterial hypertension and lung transplantation","volume":"5","author":"Lordan","year":"2011","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib121","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4103\/2045-8932.87297","article-title":"Surgical treatment of pulmonary hypertension: lung transplantation","volume":"1","author":"Long","year":"2011","journal-title":"Pulm Circ"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib122","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00059-005-2698-1","article-title":"Pulmonary hypertension and lung transplantation","volume":"30","author":"Kamler","year":"2005","journal-title":"Herz"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib123","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1378\/chest.105.3.837","article-title":"Single lung transplantation in patients with systemic disease","volume":"105","author":"Levine","year":"1994","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rdc.2013.10.001_bib124","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0003-4975(97)00930-2","article-title":"Lung transplantation for respiratory failure resulting from systemic disease","volume":"64","author":"Pigula","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.rdc.2013.10.001_bib125","first-page":"38","article-title":"Lung transplantation and systemic sclerosis","volume":"5","author":"Rosas","year":"2000","journal-title":"Ann Transplant"},{"issue":"122","key":"10.1016\/j.rdc.2013.10.001_bib126","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1183\/09059180.00006111","article-title":"Risk factors associated with pulmonary arterial hypertension in patients with systemic sclerosis and implications for screening","volume":"20","author":"Denton","year":"2011","journal-title":"Eur Respir Rev"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib127","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","article-title":"Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era","volume":"179","author":"Condliffe","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib129","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.33460","article-title":"Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressure","volume":"64","author":"Kovacs","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2013.10.001_bib130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00063-006-1042-8","article-title":"Pulmonary hypertension: the future has begun","volume":"101","author":"Olschewski","year":"2006","journal-title":"Med Klin (Munich)"},{"issue":"2","key":"10.1016\/j.rdc.2013.10.001_bib131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ahj.2011.05.012","article-title":"Current therapeutics and practical management strategies for pulmonary arterial hypertension","volume":"162","author":"Agarwal","year":"2011","journal-title":"Am Heart J"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:12:39Z","timestamp":1760181159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0889857X13000884"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.001","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary Arterial Hypertension Related to Connective Tissue Disease","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}